Genetically Predicted Atrial Fibrillation and Valvular Heart Disease: A Two-Sample Mendelian Randomization Study
- PMID: 35419428
- PMCID: PMC8996053
- DOI: 10.3389/fcvm.2022.845734
Genetically Predicted Atrial Fibrillation and Valvular Heart Disease: A Two-Sample Mendelian Randomization Study
Abstract
Background: Previous studies have found atrial fibrillation (AF) is associated with valvular heart disease (VHD). However, whether there is a causal relationship between these two diseases or it is just a result of bias caused by confounding factors is uncertain. This study aims to examine the potential causal association between AF and VHD by using Mendelian randomization.
Methods: In order to examine the causal relationship between AF and VHD, we performed a two-sample Mendelian randomization study by collecting exposure and outcome data from genome-wide association study (GWAS) datasets. We utilized data from FinnGen project (FinnGen, 11,258 cases for VHD including rheumatic fever, 3,108 cases for non-rheumatic VHD, and 75,137 cases for participants) and European Bio-informatics Institute database (EBI, 55,114 cases for AF and 482,295 cases for participants). Inverse-variance weighted (IVW), MR-Egger, and weighted median approaches were performed to estimate the causal effect.
Results: The Mendelian randomization analysis indicated that AF increased the risk of VHD by all three MR methods [For VHD including rheumatic fever: IVW, odds ratio (OR) = 1.255; 95% confidence interval (CI), 1.191~1.322; p = 1.23 × 10-17; Weighted median, OR = 1.305, 95% CI, 1.216~1.400, p = 1.57 × 10-13; MR-Egger, OR = 1.250, 95% CI, 1.137~1.375, p = 1.69 × 10-5; For non-rheumatic VHD: IVW, OR = 1.267; 95% CI, 1.169~1.372; p = 6.73 × 10-9; Weighted median, OR = 1.400; 95% CI, 1.232~1.591; p = 2.40 × 10-7; MR-Egger, OR = 1.308; 95% CI, 1.131~1.513; p = 5.34 × 10-4]. After the one outlier SNP was removed by heterogeneity test, the results remained the same. No horizontal pleiotropic effects were observed between AF and VHD.
Conclusions: Our study provides strong evidence of a causal relationship between AF and VHD. Early intervention for AF patients may reduce the risk of developing into VHD.
Keywords: Mendelian randomization (MR); atrial fibrillation (AF); genome-wide association study (GWAS); risk; valvular heart disease (VHD).
Copyright © 2022 Gao, Bai and Ji.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




References
-
- Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C, et al. . 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. (2021) 42:373-498. 10.1093/eurheartj/ehab648 - DOI - PubMed
-
- Dietz MF, Goedemans L, Vo NM, Prihadi EA, van der Bijl P, Gersh BJ, et al. . Prognostic implications of significant isolated tricuspid regurgitation in patients with atrial fibrillation without left-sided heart disease or pulmonary hypertension. Am J Cardiol. (2020) 135:84-90. 10.1016/j.amjcard.2020.08.034 - DOI - PubMed
-
- Vo NM, Leung M, van Rosendael PJ, Goedemans L, van Wijngaarden SE, Prihadi EA, et al. . Characteristics and prognosis of patients with nonvalvular atrial fibrillation and significant valvular heart disease referred for electrical cardioversion. Am J Cardiol. (2020) 128:84-91. 10.1016/j.amjcard.2020.04.035 - DOI - PubMed
-
- Banerjee A, Allan V, Denaxas S, Shah A, Kotecha D, Lambiase PD, et al. . Subtypes of atrial fibrillation with concomitant valvular heart disease derived from electronic health records: phenotypes, population prevalence, trends and prognosis. Europace. (2019) 21:1776-84. 10.1093/europace/euz220 - DOI - PMC - PubMed